The Human VEGF (Vascular Endothelial Growth Factor) ELISA Kit from Assay Genie is a powerful tool for the precise measurement of VEGF levels in human samples such as serum, plasma, and cell culture supernatants. With its exceptional sensitivity and specificity, this kit delivers accurate and reproducible results, making it a valuable asset for a wide range of research endeavors. VEGF is a key factor in angiogenesis, playing a critical role in the formation of new blood vessels and influencing cell growth and survival.
Its dysregulation has been implicated in various diseases including cancer, cardiovascular conditions, and inflammatory disorders. By accurately measuring VEGF levels, researchers can gain insights into disease mechanisms and potentially identify new therapeutic targets. Trust the Human VEGF ELISA Kit from Assay Genie for precise and reliable detection of VEGF levels, allowing for in-depth exploration of angiogenesis-related processes and diseases.
Product Name:
Human VEGF ELISA Kit
SKU:
HUFI00281
Reactivity:
Human
Assay Type:
Sandwich ELISA, Double Antibody
Sensitivity:
18.75 pg/mL
Range:
31.25-2000 pg/mL
Sample Type:
Serum, Plasma, Cell Culture Supernatant, Cell or Tissue Lysate, Other Liquid Samples
Storage:
2-8°C for 12 months.
Linearity:
Sample
1:2
1:4
1:8
Serum (n = 5)
86-105%
85-101%
88-104%
EDTA Plasma (n = 5)
86-100%
85-99%
94-100%
Heparin Plasma (n = 5)
80-92%
85-97%
83-100%
Recovery:
Sample
Recovery Range (%)
Average (%)
Serum (n = 5)
88-104
98
EDTA Plasma (n = 5)
85-102
94
Heparin Plasma (n = 5)
91-105
100
Note:The below protocol is a sample protocol. Protocols are specific to each batch/lot. For the correct instructions please follow the protocol included in your kit.
Step
Procedure
1
Reagent & Plate Preparation: Equilibrate reagents and TMB substrate to room temperature. Set standard, test sample and control (zero) wells on the pre-coated plate and record their positions.
2
Primary Incubation: Prepare standards, samples, blanks and load into designated wells. Incubate plate at 37°C for 90 minutes to allow antigen binding.
3
Detection Antibody Binding: Add biotin-labeled detection antibody and incubate at 37°C for 60 minutes.
4
HRP-Streptavidin Binding: Add HRP-Streptavidin (SABC) and incubate at 37°C for 30 minutes.
5
Color Development: Add TMB substrate and incubate in the dark for 10–20 minutes.
6
Stop Reaction & Reading: Add stop solution and measure absorbance at 450 nm immediately.
Sample Type
Protocol
Serum
Allow blood to clot, centrifuge at 1000 × g for 20 minutes, collect supernatant supernatant and store appropriately.
Plasma
Collect using anticoagulant tubes, centrifuge at 1000 × g for 15 minutes at 2–8°C and collect plasma.
Tissue Homogenate
Homogenize tissue in PBS with protease inhibitors, centrifuge and collect supernatant.
Cell Culture Supernatant
Centrifuge at 2500 rpm for 5 minutes and collect clarified supernatant.
Cell Lysate
Lyse cells using lysis buffer with protease inhibitors, centrifuge and collect protein supernatant.
Other Sample Types
For more information about how to process other sample types, (e.g., body fluids, breast milk & more), please contact our Tech Support Team at techsupport@assaygenie.com.
Component
Quantity
Storage
48T
96T
ELISA Microplate (Dismountable)
8×6
8×12
Place the test strips into a sealed foil bag with the desiccant. Store for 1 month at 2-8°C; Store for 12 months at -20°C.
Lyophilized Standard
1 vial
2 vial
Place the standards into a sealed foil bag with the desiccant. Store for 1 month at 2-8°C; Store for 12 months at -20°C.
Biotin-labeled Antibody (Concentrated, 100X)
60 ul
120 ul
2-8°C (Avoid direct light)
HRP-Streptavidin Conjugate (SABC, 100X)
60 ul
120 ul
2-8°C (Avoid direct light)
TMB Substrate
5 ml
10 ml
2-8°C (Avoid direct light)
Sample Dilution Buffer
10 ml
20 ml
2-8°C
Antibody Dilution Buffer
5 ml
10 ml
2-8°C
SABC Dilution Buffer
5 ml
10 ml
2-8°C
Stop Solution
5 ml
10 ml
2-8°C
Wash Buffer(25X)
15 ml
30 ml
2-8°C
Plate Sealer
3 pieces
5 pieces
-
Technical Manual
1 copy
1 copy
-
Neíll, T., et al.
Restoring disc matrix homeostasis: Dual-miRNA and human platelet lysate as a novel therapeutic strategy
Circulating miRNA-122 and miRNA-223 expression signatures across TNM stages of hepatocellular carcinoma in Egyptian patients: association with angiogenesis, apoptosis, and autophagy-related biomarker
